Haryana, India

Nilendu Panda



Average Co-Inventor Count = 7.1

ph-index = 3

Forward Citations = 33(Granted Patents)


Location History:

  • Gurgaon, IN (2014 - 2016)
  • Haryana, IN (2014 - 2022)

Company Filing History:


Years Active: 2014-2022

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Nilendu Panda

Introduction

Nilendu Panda, an accomplished inventor based in Haryana, India, has made significant contributions to the field of pharmaceuticals. With a total of seven patents to his name, he has demonstrated a consistent commitment to advancing medical technology and improving patient care.

Latest Patents

Among his notable inventions are the patented innovations related to "Polymorphic forms of Afatinib free base and Afatinib dimaleate." These inventions focus on the development of crystalline forms of Afatinib and its dimaleate salt. Nilendu's work also includes the processes for the preparation of these crystalline forms and the formulation of pharmaceutical compositions. The innovations have potential applications in the treatment of patients, showcasing his dedication to enhancing therapeutic options.

Career Highlights

Nilendu Panda currently works at Fresenius Kabi Oncology Limited, a leading company in the oncology sector. His position at this reputable organization allows him to apply his expertise and drive innovations in cancer treatment.

Collaborations

Throughout his career, Nilendu has collaborated with several talented professionals, including his coworkers Saswata Lahiri and Bhuwan Bhaskar Mishra. These partnerships have enabled the sharing of knowledge and resources, further fueling his inventive endeavors and contributing to successful patent applications.

Conclusion

Nilendu Panda stands out as a prominent inventor in the pharmaceutical industry, with his innovative patents having the potential to bring about significant advancements in cancer treatment. His dedication and collaborative spirit reflect his commitment to improving patient outcomes and driving scientific progress.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…